These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11234357)

  • 21. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens.
    Cunningham ML; Matthews HB
    Toxicol Lett; 1995 Dec; 82-83():9-14. PubMed ID: 8597159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impurities.
    Galloway SM; Vijayaraj Reddy M; McGettigan K; Gealy R; Bercu J
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):326-35. PubMed ID: 23688841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The hygienic evaluation of the mutagenic potential of industrial wastes].
    Zhurkov VS; Rusakov NV; Tonkopiĭ NI; Sycheva LP; Akhal'tseva LV; Neiaskina EV; Pirtakhiia NV; Malysheva AG; Rastiannikov EG
    Gig Sanit; 1998; (4):30-2. PubMed ID: 9721500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML; Hayward JJ; Shane BS; Tindall KR
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenic and carcinogenic hazards of settled house dust. II: Salmonella mutagenicity.
    Maertens RM; Gagné RW; Douglas GR; Zhu J; White PA
    Environ Sci Technol; 2008 Mar; 42(5):1754-60. PubMed ID: 18441831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenic carcinogens and noncarcinogens in transgenic mice.
    Günzel P; Reimann R
    Environ Health Perspect; 1997 Feb; 105(2):163. PubMed ID: 9105788
    [No Abstract]   [Full Text] [Related]  

  • 27. CPDB: Carcinogenic Potency Database.
    Fitzpatrick RB
    Med Ref Serv Q; 2008; 27(3):303-11. PubMed ID: 19042710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative micronucleated erythrocyte cell induction in three cyprinids by five carcinogenic-mutagenic chemicals.
    Al-Sabti K
    Cytobios; 1986; 47(190-191):147-54. PubMed ID: 3792051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis.
    Ellis P; Kenyon M; Dobo K
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):201-13. PubMed ID: 23228434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic toxicology: current status of methods of carcinogen identification.
    Tennant RW; Zeiger E
    Environ Health Perspect; 1993 Apr; 100():307-15. PubMed ID: 8354178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of antioxidants to minimize the human health risk associated to mutagenic/carcinogenic heterocyclic amines in food.
    Vitaglione P; Fogliano V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):189-99. PubMed ID: 15036011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites.
    Heflich RH; Neft RE
    Mutat Res; 1994 Oct; 318(2):73-114. PubMed ID: 7521935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity, carcinogenicity and teratogenicity of germanium compounds.
    Gerber GB; Léonard A
    Mutat Res; 1997 Dec; 387(3):141-6. PubMed ID: 9439710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mutagenic Activity of Four Aminoazo Compounds with Different Carcinogenicity for Rat Liver in the Ames Test].
    Frolova TS; Sinitsyna OI; Kaledin VI
    Biofizika; 2015; 60(5):990-4. PubMed ID: 26591610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation--a comparative study on mutagens and carcinogens.
    Ishidate M; Yoshikawa K
    Arch Toxicol Suppl; 1980; 4():41-4. PubMed ID: 7002106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclopenta-polycyclic aromatic hydrocarbons: potential carcinogens and mutagens.
    Fu PP; Beland FA; Yang SK
    Carcinogenesis; 1980 Aug; 1(8):725-7. PubMed ID: 11272127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that toxic injury is not always associated with induction of chemical carcinogenesis.
    Tennant RW; Elwell MR; Spalding JW; Griesemer RA
    Mol Carcinog; 1991; 4(6):420-40. PubMed ID: 1793481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The carcinogenic and genotoxic action of the substances in the exhaust gases from internal combustion engines].
    Makhover MS; Khesina AIa
    Eksp Onkol; 1990; 12(5):11-4, 34. PubMed ID: 1699721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.